Pharma
Apollo Hospitals Enterprise Ltd
APOLLOHOSP · NSE · INE437A01024Vol: 9.9L traded · 63.0% delivered
Market Cap—
P/E—
P/B—
EPS—
Div Yield—
ROE22.6%
ROCE17.0%
ROE22.6%
1Y Return+14.32%
Avg. Volume0.4M
Delivery %62.97%
Price Chart
About
Apollo Hospitals Enterprise Ltd is a Pharma company listed on NSE.
Technicals
Free account
Register freeTechnicals
Create a free account to view momentum, moving averages, and delivery signals.
Quant
Premium
UpgradeQuant metrics
Upgrade to view volatility, drawdown, factor, and risk metrics.
Key Ratios
Market Cap—
Current Price—
52W High / Low—
Stock P/E—
Price to Book—
EPS (TTM)—
Dividend Yield—
ROE22.6%
1Y Return+14.32%
Day Change—
Profit & Loss
| Period | TTM | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | ₹26,430 Cr | ₹25,228 Cr | ₹21,794 Cr | ||||||||||
| Expenses | ₹22,420 Cr | ₹21,449 Cr | ₹18,761 Cr | ||||||||||
| Operating Profit | ₹4,010 Cr | ₹3,779 Cr | ₹3,033 Cr | ||||||||||
| OPM % | 15.0% | 15.0% | 14.0% | ||||||||||
| Other Income | ₹226 Cr | ₹207 Cr | ₹222 Cr | ||||||||||
| Depreciation | ₹896 Cr | ₹876 Cr | ₹758 Cr | ||||||||||
| Interest | ₹462 Cr | ₹450 Cr | ₹458 Cr | ||||||||||
| Profit Before Tax | ₹2,877 Cr | ₹2,661 Cr | ₹2,039 Cr | ||||||||||
| Tax | ₹705 Cr | ₹658 Cr | ₹534 Cr | ||||||||||
| Net Profit | ₹2,172 Cr | ₹2,003 Cr | ₹1,505 Cr | ||||||||||
| EPS (₹) | 145.3 | 135.0 | 100.6 | ||||||||||
| Dividend Payout % | — | 15% | 13% |
Financial history locked
Register freeRegister free to see 10 more years.
Quarterly Results
| Quarter | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | ₹7,044 Cr | ₹6,606 Cr | ₹6,477 Cr | ₹6,304 Cr | |||||||||
| Expenses | ₹5,951 Cr | ₹5,594 Cr | ₹5,512 Cr | ₹5,362 Cr | |||||||||
| Operating Profit | ₹1,092 Cr | ₹1,011 Cr | ₹965 Cr | ₹941 Cr | |||||||||
| OPM % | 16.0% | 15.0% | 15.0% | 15.0% | |||||||||
| Depreciation | ₹235 Cr | ₹224 Cr | ₹219 Cr | ₹218 Cr | |||||||||
| Interest | ₹120 Cr | ₹119 Cr | ₹113 Cr | ₹110 Cr | |||||||||
| Net Profit | ₹610 Cr | ₹551 Cr | ₹516 Cr | ₹494 Cr | |||||||||
| EPS (₹) | 40.4 | 36.8 | 34.9 | 33.2 |
Quarterly history locked
Register freeRegister free to see 9 more quarters.
Balance Sheet
| Period | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity Capital | ₹72 Cr | ₹72 Cr | ₹72 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reserves | ₹9,408 Cr | ₹8,140 Cr | ₹6,864 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Borrowings | ₹8,493 Cr | ₹7,864 Cr | ₹5,333 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Liabilities | ₹4,210 Cr | ₹4,568 Cr | ₹4,473 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Liabilities | ₹22,183 Cr | ₹20,644 Cr | ₹16,742 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fixed Assets | ₹12,272 Cr | ₹10,988 Cr | ₹9,664 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments | ₹2,179 Cr | ₹2,487 Cr | ₹986 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Receivables | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inventory | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash & Equivalents | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Assets | ₹6,700 Cr | ₹6,248 Cr | ₹5,219 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Assets | ₹22,183 Cr | ₹20,644 Cr | ₹16,742 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance sheet history locked
Register freeRegister free to see 10 more years.
Cash Flow
| Period | Operating | Investing | Financing | Net Cash Flow |
|---|---|---|---|---|
| FY26 | ₹2,856 Cr | ₹-2,145 Cr | ₹-478 Cr | ₹233 Cr |
| FY25 | ₹2,136 Cr | ₹-3,383 Cr | ₹1,319 Cr | ₹73 Cr |
| FY24 | ₹1,920 Cr | ₹-1,537 Cr | ₹-311 Cr | ₹72 Cr |
| FY23 | ||||
| FY22 | ||||
| FY21 | ||||
| FY20 | ||||
| FY19 | ||||
| FY18 | ||||
| FY17 | ||||
| FY16 | ||||
| FY15 |
Cash flow history locked
Register freeRegister free to see 10 more years.
Peer Comparison
| Company | M.Cap | P/E | ROE | 1Y Return |
|---|---|---|---|---|
| 3B BlackBio Dx Ltd | ₹1,210 Cr | 21.4 | +20.2% | +17.9% |
| Aarey Drugs & Pharmaceuticals Ltd | ₹353 Cr | 75.3 | +2.75% | +59.84% |
| Aarti Drugs Ltd | ₹3,429 Cr | 18.0 | +13.37% | +11.57% |
| Aarti Pharmalabs Ltd | ₹7,495 Cr | 35.2 | +8.51% | +14.26% |
| Abbott India Ltd | — | — | +34.46% | -7.16% |
Mutual Fund Holdings
Free account
Register freeMutual fund holdings
Create a free account to see institutional ownership snapshots.
Bulk & Block Deals
Free account
Register freeBulk & block deals
Create a free account to view recent institutional deal activity.
Analyst Estimates
Free account
Register freeAnalyst estimates
Create a free account to view analyst estimate summaries.
Latest News
2026-10-16Intimation Of Schedule Of Analyst/ Institutional Investors MeetingBSE Filing2026-08-13Apollo Hospitals Enterprise Ltd (BOM:508869) (Q1 2027) Earnings Call Highlights: Revenue Surges ...GuruFocus.com2026-08-13From Prevention to Lifelong Care: India's First Comprehensive LE&RN-Accredited Lymphedema Clinic Opens at Apollo AthenaaPR Newswire2026-07-29Apollo Hospitals Pune Performs Its First Robotic-Assisted Coronary Artery Bypass SurgeryPR Newswire2026-07-21Apollo Hospitals Brings Next-Generation Lysin Science to India's Fight Against AMR - Collaborates with Precisio BiotixPR Newswire
Documents & Filings
rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.